Cambridge Company's Newly Approved ALS Drug Offers Hope for Families
A Cambridge company has won approval for a new drug to treat ALS. For many families, it brings a new sense of hope. The new drug from Cambridge-based Amylyx Pharmaceuticals Inc. is called Relyvrio. “People with ALS are some of the most strong and incredible people,” said Joshua Cohen, co-CEO and cofounder of Amylyx pharmaceuticals. Cohen and Justin Klee...
FDA Approves New ALS Drug Made by Company in Cambridge
The FDA approved the drug based on results from a small, mid-stage study where ALS patients appeared to progress more slowly and survive several months longer.
Decision on FDA Approval Expected for ALS Drug
The drug could potentially be a gamechanger in the battle against ALS by extending the lives of people with the condition.
Zac Brown Band's John Driskell Hopkins Shares ALS Diagnosis
The bassist for the Zac Brown Band announced he has been diagnosed with ALS.
FDA Panel Narrowly Sides Against Experimental ALS Drug
U.S. health advisers have narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease
FDA Skeptical of Benefits From Experimental ALS Drug
The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease
Biden Signs Bills on Forced Labor in China, ALS Research
President Joe Biden has signed a bill into law to block imports from China’s Xinjiang region unless businesses can prove the items were made without using forced labor